Zandu Pharmaceuticals manufactures pharmaceutical preparations. The company specialises in ayurvedic products such as Ghritas, Churna and medicinal oils. The products of the company are sold under the brand name 'Zandu'.
ZANDU REALTY | BRIGADE ENTERPRISES | ZANDU REALTY/ BRIGADE ENTERPRISES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 24.2 | 29.9 | 80.9% | View Chart |
P/BV | x | 0.7 | 1.6 | 46.3% | View Chart |
Dividend Yield | % | 0.0 | 0.8 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZANDU REALTY Mar-14 |
BRIGADE ENTERPRISES Mar-19 |
ZANDU REALTY/ BRIGADE ENTERPRISES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,269 | 309 | 411.2% | |
Low | Rs | 789 | 157 | 502.2% | |
Sales per share (Unadj.) | Rs | 358.5 | 218.4 | 164.1% | |
Earnings per share (Unadj.) | Rs | 474.4 | 20.7 | 2,290.6% | |
Cash flow per share (Unadj.) | Rs | 474.4 | 31.0 | 1,530.5% | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 0.9 | 0.0% | |
Book value per share (Unadj.) | Rs | 2,630.2 | 159.4 | 1,650.1% | |
Shares outstanding (eoy) | m | 0.81 | 136.10 | 0.6% | |
Bonus/Rights/Conversions | - | ESOP | - | ||
Price / Sales ratio | x | 2.9 | 1.1 | 269.2% | |
Avg P/E ratio | x | 2.2 | 11.2 | 19.3% | |
P/CF ratio (eoy) | x | 2.2 | 7.5 | 28.9% | |
Price / Book Value ratio | x | 0.4 | 1.5 | 26.8% | |
Dividend payout | % | 0 | 9.7 | 0.0% | |
Avg Mkt Cap | Rs m | 833 | 31,691 | 2.6% | |
No. of employees | `000 | NA | 0.8 | 0.0% | |
Total wages/salary | Rs m | 0 | 1,879 | 0.0% | |
Avg. sales/employee | Rs Th | NM | 38,758.5 | - | |
Avg. wages/employee | Rs Th | NM | 2,449.8 | - | |
Avg. net profit/employee | Rs Th | NM | 3,675.4 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 290 | 29,728 | 1.0% | |
Other income | Rs m | 274 | 545 | 50.4% | |
Total revenues | Rs m | 565 | 30,273 | 1.9% | |
Gross profit | Rs m | 225 | 7,897 | 2.8% | |
Depreciation | Rs m | 0 | 1,400 | 0.0% | |
Interest | Rs m | 3 | 2,785 | 0.1% | |
Profit before tax | Rs m | 496 | 4,257 | 11.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 18 | 0.0% | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 111 | 1,455 | 7.6% | |
Profit after tax | Rs m | 384 | 2,819 | 13.6% | |
Gross profit margin | % | 77.3 | 26.6 | 291.0% | |
Effective tax rate | % | 22.4 | 34.2 | 65.6% | |
Net profit margin | % | 132.3 | 9.5 | 1,395.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,439 | 57,618 | 2.5% | |
Current liabilities | Rs m | 560 | 49,579 | 1.1% | |
Net working cap to sales | % | 302.5 | 27.0 | 1,118.7% | |
Current ratio | x | 2.6 | 1.2 | 221.0% | |
Inventory Days | Days | 1,310 | 591 | 221.6% | |
Debtors Days | Days | 0 | 52 | 0.0% | |
Net fixed assets | Rs m | 0 | 30,764 | 0.0% | |
Share capital | Rs m | 81 | 1,362 | 5.9% | |
"Free" reserves | Rs m | 1,032 | 20,332 | 5.1% | |
Net worth | Rs m | 2,131 | 21,694 | 9.8% | |
Long term debt | Rs m | 0 | 33,156 | 0.0% | |
Total assets | Rs m | 2,691 | 107,999 | 2.5% | |
Interest coverage | x | 146.7 | 2.5 | 5,803.6% | |
Debt to equity ratio | x | 0 | 1.5 | 0.0% | |
Sales to assets ratio | x | 0.1 | 0.3 | 39.2% | |
Return on assets | % | 14.4 | 5.2 | 277.7% | |
Return on equity | % | 18.0 | 13.0 | 138.8% | |
Return on capital | % | 23.4 | 12.9 | 181.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 19 | 0.0% | |
Fx outflow | Rs m | 0 | 40 | 0.0% | |
Net fx | Rs m | 0 | -20 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 656 | 4,672 | 14.0% | |
From Investments | Rs m | -627 | -4,520 | 13.9% | |
From Financial Activity | Rs m | NA | 448 | -0.0% | |
Net Cashflow | Rs m | 29 | 600 | 4.8% |
Indian Promoters | % | 35.5 | 57.5 | 61.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.3 | 3.0 | 9.9% | |
FIIs | % | 0.0 | 4.6 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 64.2 | 34.9 | 184.0% | |
Shareholders | 27,223 | 66,193 | 41.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ZANDU REALTY With: KOLTE PATIL JAIPRAKASH ASSO SOBHA PHOENIX MILL J KUMAR INFRA
Asian stock markets are trading on a strong note today. The Hang Seng is trading up by 2% while the Shanghai Composite is up 0.6%. The Nikkei is trading higher by 0.4%.
For the quarter ended December 2019, BRIGADE ENTERPRISES has posted a net profit of Rs 405 m (down 31.9% YoY). Sales on the other hand came in at Rs 6 bn (down 19.7% YoY). Read on for a complete analysis of BRIGADE ENTERPRISES's quarterly results.
Should you apply for the IPO of Mindspace Business Parks REIT?
For the quarter ended September 2019, BRIGADE ENTERPRISES has posted a net profit of Rs 372 m (down 57.1% YoY). Sales on the other hand came in at Rs 7 bn (down 11.0% YoY). Read on for a complete analysis of BRIGADE ENTERPRISES's quarterly results.
Here's an analysis of the annual report of BRIGADE ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BRIGADE ENTERPRISES. Also includes updates on the valuation of BRIGADE ENTERPRISES.
For the quarter ended March 2019, BRIGADE ENTERPRISES has posted a net profit of Rs 717 m (up 366.8% YoY). Sales on the other hand came in at Rs 8 bn (up 75.3% YoY). Read on for a complete analysis of BRIGADE ENTERPRISES's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More